U.S. markets open in 2 hours 25 minutes
  • S&P Futures

    4,062.00
    -13.50 (-0.33%)
     
  • Dow Futures

    34,343.00
    -116.00 (-0.34%)
     
  • Nasdaq Futures

    11,990.25
    -20.00 (-0.17%)
     
  • Russell 2000 Futures

    1,888.80
    -5.60 (-0.30%)
     
  • Crude Oil

    82.34
    +2.36 (+2.95%)
     
  • Gold

    1,807.80
    -1.80 (-0.10%)
     
  • Silver

    23.19
    -0.06 (-0.26%)
     
  • EUR/USD

    1.0571
    +0.0040 (+0.38%)
     
  • 10-Yr Bond

    3.5060
    0.0000 (0.00%)
     
  • Vix

    20.00
    +0.16 (+0.81%)
     
  • GBP/USD

    1.2287
    -0.0010 (-0.08%)
     
  • USD/JPY

    135.1700
    +0.8990 (+0.67%)
     
  • BTC-USD

    17,309.45
    +353.01 (+2.08%)
     
  • CMC Crypto 200

    410.38
    +8.96 (+2.23%)
     
  • FTSE 100

    7,584.74
    +28.51 (+0.38%)
     
  • Nikkei 225

    27,820.40
    +42.50 (+0.15%)
     

Smith & Nephew's Implant Shows 86% Reduction In Re-Tear Rates After Shoulder Surgery

  • Smith & Nephew plc (NYSE: SNNannounced new data furthering several published studies supporting the use of its REGENETEN Bioinductive Implant in rotator cuff repair.

  • The REGENETEN Bioinductive Implant is part of Smith & Nephew's Advanced Healing Solutions portfolio.

  • The goal of rotator cuff repair surgery is to help restore the shoulder's function and flexibility and relieve the pain that other treatments can't control.

  • Also Read: Smith & Nephew Shares Fall On Lower Margins As Cost Headwinds Hit Q2 Profit.

  • Interim analysis from a randomized controlled trial shows a significant reduction in the re-tear rate of full-thickness rotator cuff repairs when using the REGENETEN Bioinductive Implant.

  • At 12 months follow-up, repairs with the added REGENETEN Bioinductive Implant resulted in significantly lower re-tear rates than those with a TOE repair alone.

  • Specifically, patients who received a REGENETEN Bioinductive Implant presented a re-tear rate of 3.5%. (n=29).

  • Patients who received a transosseous equivalent repair alone presented a re-tear rate of 25%, which is in line with published re-tear rates on similar tear types.

  • There were no differences in postoperative complications between groups.

  • Price Action: SNN shares are trading lower by 1.85% at $24.93 on the last check Wednesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.